• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体链球菌抑制剂(SIC)通过阻止C567摄取到细胞膜上而抑制膜攻击复合物。

Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

作者信息

Fernie-King B A, Seilly D J, Willers C, Würzner R, Davies A, Lachmann P J

机构信息

Microbial Immunology Group, Centre for Veterinary Science, University of Cambridge; Institute for Hygiene and Social Medicine, Leopold Franzens University, Innsbruck, Austria.

出版信息

Immunology. 2001 Jul;103(3):390-8. doi: 10.1046/j.1365-2567.2001.01249.x.

DOI:10.1046/j.1365-2567.2001.01249.x
PMID:11454069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1783247/
Abstract

Streptococcal inhibitor of complement (SIC) was first described in 1996 as a putative inhibitor of the membrane attack complex of complement (MAC). SIC is a 31 000 MW protein secreted in large quantities by the virulent Streptococcus pyogenes strains M1 and M57, and is encoded by a gene which is extremely variable. In order to study further the interactions of SIC with the MAC, we have made a recombinant form of SIC (rSIC) in Escherichia coli and purified native M1 SIC which was used to raise a polyclonal antibody. SIC prevented reactive lysis of guinea pig erythrocytes by the MAC at a stage prior to C5b67 complexes binding to cell membranes, presumably by blocking the transiently expressed membrane insertion site on C7. The ability of SIC and clusterin (another putative fluid phase complement inhibitor) to inhibit complement lysis was compared, and found to be equally efficient. In parallel, by enzyme-linked immunosorbent assay both SIC and rSIC bound strongly to C5b67 and C5b678 complexes and to a lesser extent C5b-9, but only weakly to individual complement components. The implications of these data for virulence of SIC-positive streptococci are discussed, in light of the fact that Gram-positive organisms are already protected against complement lysis by the presence of their peptidoglycan cell walls. We speculate that MAC inhibition may not be the sole function of SIC.

摘要

链球菌补体抑制剂(SIC)于1996年首次被描述为补体膜攻击复合物(MAC)的一种假定抑制剂。SIC是一种分子量为31000的蛋白质,由强毒化脓性链球菌M1和M57菌株大量分泌,由一个极具变异性的基因编码。为了进一步研究SIC与MAC的相互作用,我们在大肠杆菌中制备了重组形式的SIC(rSIC),并纯化了天然M1 SIC,用于制备多克隆抗体。SIC在C5b67复合物结合到细胞膜之前的阶段阻止了MAC对豚鼠红细胞的反应性溶解,推测是通过阻断C7上瞬时表达的膜插入位点。比较了SIC和聚集素(另一种假定的液相补体抑制剂)抑制补体溶解的能力,发现它们同样有效。同时,通过酶联免疫吸附测定,SIC和rSIC都与C5b67和C5b678复合物强烈结合,与C5b - 9的结合较弱,但与单个补体成分的结合仅为弱阳性。鉴于革兰氏阳性菌已经通过其肽聚糖细胞壁的存在而免受补体溶解的影响,讨论了这些数据对SIC阳性链球菌毒力的影响。我们推测MAC抑制可能不是SIC的唯一功能。

相似文献

1
Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.补体链球菌抑制剂(SIC)通过阻止C567摄取到细胞膜上而抑制膜攻击复合物。
Immunology. 2001 Jul;103(3):390-8. doi: 10.1046/j.1365-2567.2001.01249.x.
2
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.补体链球菌抑制剂可抑制黏膜固有免疫系统的另外两种成分:分泌型白细胞蛋白酶抑制剂和溶菌酶。
Infect Immun. 2002 Sep;70(9):4908-16. doi: 10.1128/IAI.70.9.4908-4916.2002.
3
Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.伯氏疏螺旋体的血清抗性菌株通过表达一种CD59样补体抑制分子来逃避补体介导的杀伤作用。
J Immunol. 2003 Mar 15;170(6):3214-22. doi: 10.4049/jimmunol.170.6.3214.
4
Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.补体成分C5和C7的重组C345C及因子I模块可抑制C7掺入补体膜攻击复合物。
J Immunol. 2005 May 15;174(10):6227-32. doi: 10.4049/jimmunol.174.10.6227.
5
Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.蛋白质SIC,一种干扰补体功能的化脓性链球菌新型细胞外蛋白。
J Biol Chem. 1996 Jan 12;271(2):1081-8. doi: 10.1074/jbc.271.2.1081.
6
Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.肺炎链球菌磷酸甘油酸激酶是一种影响膜攻击复合物形成的新型补体抑制剂。
J Biol Chem. 2014 Nov 21;289(47):32499-511. doi: 10.1074/jbc.M114.610212. Epub 2014 Oct 3.
7
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.人类对补体链球菌抑制剂的免疫反应,补体链球菌抑制剂是一种参与流行病传播的A群1型血清型链球菌胞外蛋白。
J Infect Dis. 2000 Nov;182(5):1425-36. doi: 10.1086/315882. Epub 2000 Oct 3.
8
Characterization of a complement-binding protein, DRS, from strains of Streptococcus pyogenes containing the emm12 and emm55 genes.对来自含有emm12和emm55基因的化脓性链球菌菌株的一种补体结合蛋白DRS的特性分析。
Infect Immun. 2004 Jul;72(7):3981-6. doi: 10.1128/IAI.72.7.3981-3986.2004.
9
Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.补体膜攻击复合物中C9的分子组织。C5b-8组装诱导C9环状聚合。
J Exp Med. 1982 Jul 1;156(1):268-82. doi: 10.1084/jem.156.1.268.
10
Membrane attack by complement.补体介导的膜攻击。
Mol Immunol. 1984 Jul;21(7):589-603. doi: 10.1016/0161-5890(84)90044-0.

引用本文的文献

1
The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential.补体系统与病原体之间的生死较量:清除机制、逃避策略及转化潜力
Virulence. 2025 Dec;16(1):2553781. doi: 10.1080/21505594.2025.2553781. Epub 2025 Sep 4.
2
Characterization of a novel SNP identified in Australian group A isolates derived from the M1 lineage.对源自M1谱系的澳大利亚A群分离株中鉴定出的一种新型单核苷酸多态性的特征分析。
mBio. 2025 Feb 5;16(2):e0336624. doi: 10.1128/mbio.03366-24. Epub 2024 Dec 17.
3
Scabies.疥疮。
Nat Rev Dis Primers. 2024 Oct 3;10(1):74. doi: 10.1038/s41572-024-00552-8.
4
Mechanisms that potentially contribute to the development of post-streptococcal glomerulonephritis.可能导致链球菌后肾小球肾炎发展的机制。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae024.
5
Interplay between group A and host innate immune responses.A 组群与宿主固有免疫反应的相互作用。
Microbiol Mol Biol Rev. 2024 Mar 27;88(1):e0005222. doi: 10.1128/mmbr.00052-22. Epub 2024 Mar 7.
6
Microbial evasion of the complement system: a continuous and evolving story.微生物逃避补体系统:一个持续不断的演变故事。
Front Immunol. 2024 Jan 4;14:1281096. doi: 10.3389/fimmu.2023.1281096. eCollection 2023.
7
Methods to Analyze the Contribution of Complement Evasion Factor (CEF) to Streptococcus pyogenes Virulence.分析补体逃逸因子 (CEF) 对化脓性链球菌毒力贡献的方法。
Methods Mol Biol. 2023;2674:119-129. doi: 10.1007/978-1-0716-3243-7_8.
8
Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.先天性免疫和微生物失调与化脓性汗腺炎-慢性炎症的恶性循环。
Front Immunol. 2022 Jul 28;13:960488. doi: 10.3389/fimmu.2022.960488. eCollection 2022.
9
Complement evasion factor (CEF), a novel immune evasion factor of .补体逃逸因子(CEF),一种新型的 免疫逃逸因子。
Virulence. 2022 Dec;13(1):225-240. doi: 10.1080/21505594.2022.2027629.
10
Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease.针对补体链球菌抑制剂的疫苗诱导免疫而非自然免疫可预防侵袭性疾病。
NPJ Vaccines. 2021 Apr 22;6(1):62. doi: 10.1038/s41541-021-00326-3.

本文引用的文献

1
SELECTION OF GROUP A STREPTOCOCCI RICH IN M-PROTEIN FROM POPULATIONS POOR IN M-PROTEIN.从M蛋白含量低的人群中筛选富含M蛋白的A组链球菌。
Am J Pathol. 1964 Jan;44(1):51-60.
2
Complement and innate immunity.补体与固有免疫
Immunopharmacology. 2000 Aug;49(1-2):187-98. doi: 10.1016/s0162-3109(00)80303-3.
3
Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1.人类补体调节蛋白与A群链球菌相互作用的评估。FHL-1中高亲和力A群链球菌结合位点的鉴定。
Eur J Immunol. 2000 Apr;30(4):1243-53. doi: 10.1002/(SICI)1521-4141(200004)30:4<1243::AID-IMMU1243>3.0.CO;2-D.
4
Group A streptococci in the 1990s.20世纪90年代的A组链球菌
J Antimicrob Chemother. 2000 Feb;45 Suppl:3-12. doi: 10.1093/jac/45.suppl_1.3.
5
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.血清型M1化脓性链球菌中补体基因(sic)高变链球菌抑制剂的非极性失活显著降低小鼠黏膜定植。
Infect Immun. 2000 Feb;68(2):535-42. doi: 10.1128/IAI.68.2.535-542.2000.
6
Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.病原体通过部分借助分子模拟来避免被补体识别或清除,从而实现免疫逃逸。
Mol Immunol. 1999 Mar-Apr;36(4-5):249-60. doi: 10.1016/s0161-5890(99)00049-8.
7
Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein.含有emm12和emm55的化脓性链球菌菌株拥有一个编码远缘相关SIC蛋白的新基因。
Microb Pathog. 1999 Jan;26(1):25-33. doi: 10.1006/mpat.1998.0244.
8
Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.高变区在链球菌M蛋白中的作用:一种人类补体抑制剂的结合
J Immunol. 1998 Nov 1;161(9):4894-901.
9
Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein.通过对与毒力相关基因进行自动DNA测序,对从患有咽炎的墨西哥儿童中分离出的A组链球菌菌株进行特征分析:编码一种补体抑制蛋白的基因存在意外的大量变异。
J Clin Microbiol. 1997 Dec;35(12):3220-4. doi: 10.1128/jcm.35.12.3220-3224.1997.
10
Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.蛋白质SIC,一种干扰补体功能的化脓性链球菌新型细胞外蛋白。
J Biol Chem. 1996 Jan 12;271(2):1081-8. doi: 10.1074/jbc.271.2.1081.